Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2008
11/13/2008WO2007106456A3 Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
11/13/2008WO2007098427A3 Massively multiplexed sequencing
11/13/2008WO2007092909A3 Molecular interaction sensors
11/13/2008WO2007092473A3 Non-invasive fetal genetic screening by digital analysis
11/13/2008WO2006137838A3 Methods and compositions for diagnosing and preventing a group b streptococcal infection
11/13/2008WO2006105417A3 Compositions and methods for the identification, assessment, prevention, and therapy of neurological diseases, disorders and conditions
11/13/2008WO2006025983A3 Labeled substrate conjugates for identifying enzyme inhibitors
11/13/2008WO2004080283A3 Type 1 ryanodine receptor-based methods
11/13/2008US20080282430 Expression vector comprising nucleotide sequences coding proteins for use in generation of drought, cold, freeze, heat and salt resistant crops
11/13/2008US20080281531 Method for Diagnosing Depression
11/13/2008US20080281177 method of making an electrochemical sensor
11/13/2008US20080281176 Method of making an electrochemical sensor
11/13/2008US20080281175 Method of making an electrochemical sensor
11/13/2008US20080280955 Methods and compositions for screening and treatment of disorders of blood glucose regulation
11/13/2008US20080280848 Structures of Active Guide Rna Molecules and Method of Selection
11/13/2008US20080280844 Methods and compositions for the diagnosis and treatment of ewing's sarcoma
11/13/2008US20080280843 Methods and kits for linking polymorphic sequences to expanded repeat mutations
11/13/2008US20080280824 Compositions and methods for treatment of cancer or neurodegenerative disease with peptide based microtubule stabilizers or inhibitors
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280811 Carbonic Anhydrase-1 and 2 signal inhibitor; of Vascular Endothelial Growth Factor signal inhibitor; kallikrein, kinin pathway inhibitor; Complement-1 Inhibitor agonist; injection into vitreous or aqueous humor of the eye; candidates by tested for significant difference in level of protein, mRNA
11/13/2008US20080280782 Method for noncovalently immobilizing a biomolecule on a solid substrate and microarray produced according to the method
11/13/2008US20080280777 Method for determining the effects of external stimuli on biological pathways in living cells
11/13/2008US20080280774 Methods and Systems for Diagnosis, Prognosis and Selection of Treatment of Leukemia
11/13/2008US20080280773 Method of Nucleotide Detection
11/13/2008US20080280772 Salivary Mrna Profiling, Biomarkers and Related Methods and Kits of Parts
11/13/2008US20080280768 Reagents and Methods for Predicting Drug Resistance
11/13/2008US20080280369 Sample suspected of containing the target polynucleotide is contacted with a polycationic multichromophore and a sensor polynucleotide complementary to the target polynucleotide; kits
11/13/2008US20080280353 Hybrid nucleic acid assembly
11/13/2008US20080280321 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/13/2008US20080280320 Formulation of antigen
11/13/2008US20080280319 GSH adducts and uses thereof
11/13/2008US20080280318 Isolation and Culture of a High Purity Population of Cone Photoreceptor Cells by Tissue Dissociation and Pna-Panning, and Biological Applications Thereof
11/13/2008US20080280317 Comprehensive Characterization Of Complex Proteins At Trace Levels
11/13/2008US20080280316 Method of Detection, Separation and Identification for Expressed Trace Protein/Peptide
11/13/2008US20080280315 Strip of cloth for monitoring efficacy of lipase activity; improving detergents
11/13/2008US20080280314 Devices and methods for profiling enzyme substrates
11/13/2008US20080280313 Protozoan serine/threonine kinase for identifying modulators for use in targeted destruction tumor cells; veterinary medicine
11/13/2008US20080280312 Substrate specificity for glucose is improved by substituting another amino acid residue for the amino acid residue at position 472 and/or 475; sensors, assay kits
11/13/2008US20080280304 Using internal transcribe spacer as screening tool in detection of glycine species in food products
11/13/2008US20080280303 G-protein coupled receptors high-throughput functional assay
11/13/2008US20080280302 Using angiopoietin 2, transmembrane protease, serine 4, extracellular matrix protein 1 biomarkers for cell proliferative disorders
11/13/2008US20080280301 Using transmembrane serine protease expression as evaluative tool in detection of nervous system stem cells; regenerative medicine; tissue engineering; treating neurodegenerative
11/13/2008US20080280300 Method
11/13/2008US20080280299 Using primers specific to factor for inversion stimulation (FIS) gene sequences as tool for screening drinking water for microbial presence
11/13/2008US20080280298 Satb1: a determinant of morphogenesis and tumor metastasis
11/13/2008US20080280297 Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia
11/13/2008US20080280296 Using point of care testing to diagnose preferential viral infection of cloven-hoofed animals
11/13/2008US20080280295 Library of probes for monitoring diffentiation in blasocyst stem cells; tissue engineering and regenerative medicine
11/13/2008US20080280294 Using presence of mutation in cytochrome-c-oxidase gene as evaluative tool in prognosing/diagnosing cell prolferative disorders
11/13/2008US20080280293 Method of Examining Inflammatory Disease and Method of Screening Remedy for Imflammatory Disease
11/13/2008US20080280292 Oligonuceotide promers for non-symmetric polymerase chain reaction; gene expression analysis
11/13/2008US20080280291 Trangenic synthetase deficient in 3' to 5' exonuclease activity and/or exhibit reduced discrimination against non-conventional nucleotide for use as in situ mutagenic tools; directed protein evolution
11/13/2008US20080280290 Method and Device for the Collection and Isolation of Nucleic Acid
11/13/2008US20080280289 Using allelic variation in natural killer (NK) cell receptors gene sequences as tool in targeted destruction of tumor cells; enhancing/developing graft versus leukemia protocols
11/13/2008US20080280288 Assay Method to Predict Sensitivity of Cancer Cell to Anticancer Drug
11/13/2008US20080280287 Oligonucleotides For the Detection of Hepatitis B Virus
11/13/2008US20080280286 Compositions and Methods for Gene Expression
11/13/2008US20080280285 Systems and Methods For Testing using Microfluidic Chips
11/13/2008US20080280284 Nucleic Acid Sequences That Can Be Used as Primers and Probes in the Amplification and Detection of Hsv Dna and Method for the Amplification and Detection of Hsv Dna Using a Transcription Based Amplification
11/13/2008US20080280283 Using herpes virus concentration as evaluative tool in diagnosing physical exhaustion
11/13/2008US20080280282 Using blood monocyte-lymphocytes gene expression patterning as evaluative tool in diagnosis of cell prolliferative and digestive disorders
11/13/2008US20080279961 Telomere targeting agents as stem cells directed treatments
11/13/2008US20080279925 Method(s) of preventing, arresting, reversing and treatment of atherosclerosis
11/13/2008US20080279888 Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
11/13/2008US20080279878 Compositions of Hsp60 Peptides and Viral Antigens for Vaccination and Diagnosis
11/13/2008US20080279872 Using dendritic cells expressing chymotrypsin protein fragment as immunostimulatory tool for targeting cancer cells associated with ovarian tissue
11/13/2008US20080279870 ALK protein tyrosine kinase, cells and methods embodying and using same
11/13/2008US20080279849 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008US20080279834 Methods and Reagents for Identifying/Isolating T Regulatory (Treg) Cells and for Treating Individuals
11/13/2008US20080279828 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
11/13/2008US20080279813 Using interferon and interleukin receptor expression profiles as evaluative tools in diagnosis of cancer, autoimmune, allergic, transplant rejection and infectious disorders
11/13/2008US20080277294 Small Volume In Vitro Analyte Sensor
11/13/2008US20080277293 system for determining the concentration of analyte in a biological fluid from a patient, comprising:at least one substrate associated with at least one transducer;a piercing member adapted to pierce a site on the patient to cause blood to flow therefrom;a sensor positioned adjacent to the site
11/13/2008US20080277292 system for determining the concentration of analyte in a biological fluid from a patient, comprising:at least one substrate associated with at least one transducer;a piercing member adapted to pierce a site on the patient to cause blood to flow therefrom;a sensor positioned adjacent to the site
11/13/2008US20080277291 system for determining the concentration of analyte in a biological fluid from a patient, comprising:at least one substrate associated with at least one transducer;a piercing member adapted to pierce a site on the patient to cause blood to flow therefrom;a sensor positioned adjacent to the site
11/13/2008US20080277278 Biosensor for disease diagnosis
11/13/2008US20080277277 Biosensor membranes composed of polymers containing heterocyclic nitrogens
11/13/2008US20080277005 Microfabricated elastomeric valve and pump systems
11/13/2008US20080276455 method of making an electrochemical sensor
11/13/2008DE10362194B4 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can
11/13/2008DE102007022670A1 Verwendung von CRMP1 als Target für chronisch psychiatrische Erkrankungen Use of CRMP1 as a target for chronic psychiatric disorders
11/13/2008DE102005029810B4 Verfahren zum Nachweis von Nukleotidsequenzen, Verwendung des Verfahrens und Testbesteck A method for detecting nucleotide sequences, using the method and test kit
11/13/2008CA2723322A1 Methods for the detection of preeclampsia
11/13/2008CA2692815A1 Hcv gene
11/13/2008CA2688317A1 Use of tp modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations
11/13/2008CA2687119A1 Formulation of sugar solutions for continuous ultracentrifugation for virus purification
11/13/2008CA2686338A1 Method and device for non-invasive prenatal diagnosis
11/13/2008CA2686337A1 Detecting triazole resistance in aspergillus
11/13/2008CA2686212A1 Diagnosis of melanoma by nucleic acid analysis
11/13/2008CA2686211A1 Methods of screening for binding interaction using sets of microparticles and unique probes
11/13/2008CA2685875A1 Methods and compositions for diagnosing osteoarthritis in a feline
11/13/2008CA2685840A1 Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
11/13/2008CA2685809A1 Methods and uses realting to bemisia and thrips resistance in capsicum annuum
11/13/2008CA2685453A1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/13/2008CA2685382A1 Methods for diagnosing ischemia
11/13/2008CA2684661A1 Human diabetes susceptibility eefsec gene
11/13/2008CA2671864A1 Detection and quantification of biomolecules using mass spectrometry
11/12/2008EP1990428A1 Nucleic acid detection methods using universal priming
11/12/2008EP1990427A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction